Literature DB >> 20068255

Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial.

María Torres Lacomba1, María José Yuste Sánchez, Alvaro Zapico Goñi, David Prieto Merino, Orlando Mayoral del Moral, Ester Cerezo Téllez, Elena Minayo Mogollón.   

Abstract

OBJECTIVE: To determine the effectiveness of early physiotherapy in reducing the risk of secondary lymphoedema after surgery for breast cancer.
DESIGN: Randomised, single blinded, clinical trial.
SETTING: University hospital in Alcalá de Henares, Madrid, Spain. PARTICIPANTS: 120 women who had breast surgery involving dissection of axillary lymph nodes between May 2005 and June 2007. INTERVENTION: The early physiotherapy group was treated by a physiotherapist with a physiotherapy programme including manual lymph drainage, massage of scar tissue, and progressive active and action assisted shoulder exercises. This group also received an educational strategy. The control group received the educational strategy only. MAIN OUTCOME MEASURE: Incidence of clinically significant secondary lymphoedema (>2 cm increase in arm circumference measured at two adjacent points compared with the non-affected arm).
RESULTS: 116 women completed the one year follow-up. Of these, 18 developed secondary lymphoedema (16%): 14 in the control group (25%) and four in the intervention group (7%). The difference was significant (P=0.01); risk ratio 0.28 (95% confidence interval 0.10 to 0.79). A survival analysis showed a significant difference, with secondary lymphoedema being diagnosed four times earlier in the control group than in the intervention group (intervention/control, hazard ratio 0.26, 95% confidence interval 0.09 to 0.79).
CONCLUSION: Early physiotherapy could be an effective intervention in the prevention of secondary lymphoedema in women for at least one year after surgery for breast cancer involving dissection of axillary lymph nodes. TRIAL REGISTRATION: Current controlled trials ISRCTN95870846.

Entities:  

Mesh:

Year:  2010        PMID: 20068255      PMCID: PMC2806631          DOI: 10.1136/bmj.b5396

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


Introduction

Acquired interruption or damage to the axillary lymphatic system after surgery or radiotherapy for breast cancer can lead to regional or generalised accumulation of lymph fluid in the interstitial space, known as secondary lymphoedema.1 This condition is the most important chronic complication after dissection of the axillary lymph nodes2 3 4 5 and has a tendency to progress. Secondary lymphoedema can cause disfigurement, physical discomfort, and functional impairment. Anxiety, depression, and emotional distress are more common in patients with than without secondary lymphoedema. This can affect social relationships, undermining body image and self esteem.6 7 8 The condition may also precipitate cellulitis, erysipelas, lymphangitis, and occasionally lymphangiosarcoma.9 10 11 Reported incidence rates for secondary lymphoedema vary depending on the method used for measurement.12 Inconsistent definitions and the lack of a standard classification system have resulted in diverse incidence rates for secondary lymphoedema, ranging from 5% to 56% within two years after surgery.7 13 14 15 16 After axillary lymph node dissection the incidence of secondary lymphoedema is about 23-38% if the criterion used to identify it is a greater than 2 cm increase in upper arm circumference measured at two adjacent points compared with the circumferences in the other arm.17 Most women (71%) develop secondary lymphoedema within 12 months after surgery for breast cancer.18 19 The factors that might influence the development of secondary lymphoedema after surgery are the number of lymph nodes removed, radiotherapy to the axilla, postoperative wound infection, postsurgical drainage time, lack of mobility, and obesity.18 20 21 22 23 24 Currently, women with breast cancer have a 77% probability of surviving at least 10 years.25 26 Consequently the effective prevention and management of complications that can impair function and affect quality of life after treatment are important.15 Efforts have been made to reduce the risk of secondary lymphoedema by preoperative and postoperative counselling and education27 28 and by early detection.27 29 A randomised clinical trial on the prevention of secondary lymphoedema through exercises and an educational strategy, however, lacked sufficient evidence.30 We determined the effectiveness of an early physiotherapy programme in reducing the risk of secondary lymphoedema in women after surgery for breast cancer involving dissection of axillary lymph nodes.

Methods

We carried out a randomised, single blinded, clinical trial of women after unilateral breast cancer surgery with axillary lymph node dissection at the Príncipe de Asturias Hospital in Madrid between May 2005 and June 2007. We excluded women without axillary lymph node dissection or with bilateral breast cancer, systemic disease, locoregional recurrence, or any contraindication to physiotherapy. Eligible women gave written informed consent to participate in the study after breast cancer had been confirmed by biopsy. Each participant was assessed preoperatively and between days 3 and 5 after hospital discharge. Equal numbers of women were then randomly allocated by computer using EPIDAT version 3.1 (Xunta de Galicia, Spain)31 to either early physiotherapy and an educational strategy (early physiotherapy group) or the educational strategy only (control group). Both programmes lasted three weeks, with three visits each week. The main outcome was the incidence of secondary lymphoedema.

Follow-up

Initially we scheduled four follow-up visits: four weeks after surgery (shortly after the completion of the intervention) and three, six, and 12 months after surgery. These dates were, however, flexible, depending on the participant’s availability. At all visits lymphoedema was assessed using the same protocol. If patients experienced pain, discomfort, or any other symptoms, they could contact the physiotherapist and a visit would be arranged. If secondary lymphoedema was diagnosed then complex decongestive physiotherapy was carried out,32 33 34 which would effectively interrupt follow-up.

Interventions

Each group had one physiotherapist, who carried out all interventions. Before the study it was agreed that both groups would receive the same educational intervention. The physiotherapists had more than five years’ experience in the treatment of vascular diseases using lymphatic drainage. They were the only study members aware of group allocation. Early physiotherapy group—The intervention included the manual lymph drainage technique used for the treatment of postoperative oedema (thorax, breast, axilla, and upper arm of affected side), using a modification of the strokes described by Leduc (only resorption strokes were used)32 34; progressive massage of the scar (progressing from Jacquet and Leroy pincer to Wetterwald pincer)32 35; stretching exercises for levator scapulae, upper trapezius, pectoralis major, and medial and lateral rotators muscles of the shoulder36; and progressive active and action assisted shoulder exercises, started in conjunction with functional activities and proprioceptive neuromuscular facilitation exercises without resistance (rhythmic initiation progressing from passive to active-assistive to active movement in two diagonal symmetrical bilateral patterns and asymmetrical reciprocal patterns: D1 into flexion from hitch hike to swat fly, and into extension from swat fly to hitch hike, and D2 into flexion from hand in opposite pocket to carry tray, and into extension from carry tray to hand in opposite pocket).37 If axillary web syndrome was diagnosed the physiotherapy protocol extended the manual lymph drainage technique to axilla and to proximal ipsilateral arm and included specific thumb manual lymph drainage on the characteristics taut cords, to make them gradually more flexible. The early physiotherapy group also did shoulder exercises and stretching at home once daily during the three week intervention period. Educational strategy (both groups)—The educational strategy consisted of instruction with printed materials about the lymphatic system, concepts of normal load versus overload, the source of secondary lymphoedema, the identification of possible precipitating factors, and the four categories of interventions to prevent secondary lymphoedema (avoidance of trauma or injury, prevention of infection, avoidance of arm constriction, and use and exercise of the arm),27 28 38 39 together with individual strategies for implementing these measures.

Assessments

A different physiotherapist did the two initial and four follow-up assessments of all participants and remained blinded to group allocation. Participants were instructed not to reveal their allocation. Lymphoedema—Direct measurement of the presence and severity of lymphoedema is difficult and different diagnostic criteria have been described, including comparison between preoperative and postoperative measurements within the affected arm and comparison of measurements between the affected and unaffected arms.16 29 40 41 42 43 For our main analysis we used the criteria stated in the trial protocol—that is, a 2 cm or greater increase in the circumference of any two adjacent points compared with measurements in the other arm.19 41 44 45 46 We also carried out the analysis using other criteria (data not shown). Arm measurements—Whatever the criteria used for diagnosing lymphoedema they are all based on changes in size or volume of the arms. Arm circumferences were measured at each visit and always following the same procedure, using a standard 1 cm wide, retractable, fibreglass tailor’s tape measure (Babel, Spain). With the patient in an upright sitting position with both arms on a table, shoulders in neutral rotation and flexion of 45°, and forearms at maximum supination, we measured the circumference at 5 cm intervals along both arms, using the elbow fold as the reference starting point. This has been reported as a valid and reliable method for accurately quantifying and diagnosing secondary lymphoedema.47 48 49 Other variables—During the preoperative assessment we collected personal data on the participants, including age, ethnicity, marital status, body mass index, job, educational level, socioeconomic status, information on breast cancer, and medical history. In postoperative assessments, data were collected on the type of surgery done, the number of lymph nodes removed, the use of adjuvant treatment, and the development of seroma and infection. Participants were also asked an open question about whether they had any pain. If they did, a physical examination was carried out to find the source, including axillary web syndrome. The diagnostic criteria for axillary web syndrome were pain and restriction of range of motion in the shoulders, with associated visible or palpable taut cords of tissue in the axilla in maximal shoulder abduction.50 51 52 53 54 Other secondary outcomes were measured according to the protocol but are not reported here.

Statistical analysis

The clinical criterion we chose to determine lymphoedema (binary variable) was based on changes in circumference along the arm (continuous variable). The raw data are therefore measures of circumference. To obtain the binary outcome several intermediate variables need to be computed from these measurements (see web extra on bmj.com). The important variable here would be the maximum difference in arm circumference between any two adjacent points. A patient would have a diagnosis of secondary lymphoedema if the maximum difference between any two adjacent points was 2 cm or greater. Lymphoedema can also be determined from the increase in volume ratio of both arms (volume of affected arm divided by volume of unaffected arm). 29 30 42 44 55 56 The volume ratio is computed in the variable “change in volume ratio” (presented as percentages). Although we chose not to use this as part of our criteria for clinical diagnosis we include a continuous analysis on this variable. This variable can be easily interpreted as an increase or decrease of the proportional difference of the volumes of both arms (affected minus unaffected; see web extra on bmj.com). Total arm volume was calculated by adding up all the partial volumes between every two adjacent measurements. Each of these partial volumes was calculated by an approximation to a truncated cone with the formula: V=D(C12+C22+C1C2)/12 π where C1 and C2 are the circumferences and the two adjacent locations and D is the distance between C1 and C2. We have not included hand volume as this is difficult to model with a truncated cone. Truncated cone calculations of limb segment volumes using the circumference of segments have been reported to be reliable.16

Power calculations and sample size

Although the sample size was limited by patients’ availability we did some power calculations. With this sample size and after 3% of dropouts, we would have a power of 70% to detect a difference of 20% in the incidence of secondary lymphoedema between the groups. This assumes an incidence of 30% in the control group (according to findings in earlier studies16 17 19 44) and setting a type I error of 0.05. Statistical analyses were done using Stata version 10.0.57 For the primary analysis we compared the groups in three ways. Firstly, we used a binary outcome analysis to compare the incidence of lymphoedema, determined according to the chosen criteria. Secondly, we used a continuous outcome analysis to compare the variables “maximum difference in arm circumference between two adjacent locations” and “change in volume ratio.” Thirdly, as we had recorded the timing of diagnosis of lymphoedema we carried out a survival analysis for the binary outcome. We compared the incidence of lymphoedema using Fisher’s exact test. Logistic regression was used when we needed to adjust for other variables. For the continuous outcomes sufficient data ensured the asymptotic properties of Student’s t tests to compare means. A Cox proportional hazard model was used to compare the survival rate between the groups.

Results

Of 120 women recruited, 60 were assigned to early physiotherapy and an educational strategy and 60 to the educational strategy only (fig 1). All variables were similarly distributed between the groups at randomisation (preoperative visit; table 1). The volume ratios were around 1 in both groups. This was expected as no lymphoedema was present at the preoperative assessment. Overall, 116 women completed the follow-up assessments; 59 in the intervention group and 57 in the control group.

Fig 1 Progress of participants through study

Table 1

 Comparison between randomised groups at baseline. Values are numbers (percentages) unless stated otherwise

VariablesSample (n=120)Early physiotherapy group (n=60)Control group (n=60)
Mean (SD) age (years)52.9 (11.6)52.9 (10.7)52.9 (12.5)
Mean (SD) body mass index27.0 (5.1)27.9 (5.6)26.2 (4.5)
Mean (SD) volume ratio at baseline*1.002 (0.04)1.004 (0.05)0.999 (0.03)
Mean (SD) maximum circumference†0.45 (0.62)0.54 (0.71)0.37 (0.51)
In employment48 (40)23 (38)25 (42)
Surgical procedure:
 Quadrantectomy50 (42)24 (40)26 (43)
 Modified mastectomy43 (36)23 (38)20 (34)
 Lumpectomy27 (22)13 (22)14 (23)
Mean (SD) No of dissected lymph nodes13.6 (5.2)13.6 (5.1)13.6 (5.4)
Mean (SD) No of days of drainage4.3 (2.1)4.1 (1.6)4.5 (2.5)
Seroma33 (28)16 (27)17 (28)
Wound infection11 (9)6 (10)5 (8)
Axillary web syndrome after surgery55 (46)26 (43)29 (48)
Postoperative therapy‡:(n=116)(n=59)(n=57)
 Radiotherapy93 (80)44 (75)49 (86)
 Chemotherapy95 (82)50 (85)45 (79)
 Hormonal therapy72 (62)39 (66)33 (58)

*Volume of affected arm to that of unaffected arm.

†Maximum difference measured between two adjacent points.

‡Excludes four patients lost to follow-up: three in early physiotherapy group and one in control group.

Fig 1 Progress of participants through study Comparison between randomised groups at baseline. Values are numbers (percentages) unless stated otherwise *Volume of affected arm to that of unaffected arm. †Maximum difference measured between two adjacent points. ‡Excludes four patients lost to follow-up: three in early physiotherapy group and one in control group. Table 2 shows the numbers of women in both groups with a diagnosis of secondary lymphoedema. The incidence of secondary lymphoedema in the control group (14 cases, 25%) was significantly higher than in the intervention group (four cases, 7%; P=0.010). Risk factors for secondary lymphoedema18 22 23 24 were similar between the groups, therefore adjustment for these was not necessary (table 1). Body mass index was higher in the intervention group, therefore the odds ratio for treatment was adjusted by body mass index (table 2). The crude effect showed no difference.
Table 2

 Comparison of secondary lymphoedema in groups

GroupEarly physiotherapy group (n=59)Control group (n=57)Odds ratio (95% CI)P value
No (%) with lymphoedema4 (7)14 (25)
Early physiotherapy v control*0.28 (0.10 to 0.79)†0.22 (0.07 to 0.73)0.010
Early physiotherapy v control‡0.22 (0.07 to 0.72)0.013

*Crude effect.

†Risk ratio (95% confidence interval).

‡Adjusted for body mass index.

Comparison of secondary lymphoedema in groups *Crude effect. †Risk ratio (95% confidence interval). ‡Adjusted for body mass index. Table 3 compares the continuous variables for the outcome (parametric tests) between the groups. By the 12 month follow-up visit the volume ratio between arms had increased in both groups: in the control group the volume of the affected arm was on average 5.1% greater than that of the unaffected arm, whereas in the intervention group the affected arm was on average only 1.6% greater than the unaffected arm. The difference between groups was significant (P=0.0065). The maximum difference between two adjacent points was on average also larger in the control group than in the intervention group (1.15 cm v 0.68 cm, P=0.0207). Figures 2 and 3 show the distributions of these variables in the groups. The distributions in the control group are more skewed to the right.
Table 3

 Continuous analysis of circumferential and volume measurements. Values are means (standard deviations) unless stated otherwise

MeasuresFollow-upEarly physiotherapy group (n=59)Control group (n=57)P value*
Change in volume ratioBaseline to 12 months1.6 (5.6)5.1 (7.6)0.0065
Maximum circumference†12 months0.68 (0.91)1.15 (1.21)0.0207

*Student’s t test.

†Maximum difference measured between two adjacent points.

Fig 2 Increase in volume ratios between arms. Vertical lines correspond to cut-off values for diagnoses of lymphoedema in other studies (>5% and >10% increase)

Fig 3 Maximum increase in arm circumference (affected arm−unaffected arm) that could be observed at least at two adjacent points. Vertical line corresponds to binary criteria used here to diagnose lymphoedema—that is, a 2 cm or greater increase in arm circumference observed at least at two adjacent points in affected arm compared with unaffected arm

Fig 2 Increase in volume ratios between arms. Vertical lines correspond to cut-off values for diagnoses of lymphoedema in other studies (>5% and >10% increase) Fig 3 Maximum increase in arm circumference (affected arm−unaffected arm) that could be observed at least at two adjacent points. Vertical line corresponds to binary criteria used here to diagnose lymphoedema—that is, a 2 cm or greater increase in arm circumference observed at least at two adjacent points in affected arm compared with unaffected arm Continuous analysis of circumferential and volume measurements. Values are means (standard deviations) unless stated otherwise *Student’s t test. †Maximum difference measured between two adjacent points. The rate of survival was better in the intervention group than in the control group. Secondary lymphoedema developed four times more rapidly in the control group (intervention group/control group, hazard ratio 0.26, 95% confidence interval 0.09 to 0.79; P=0.010). The shape of the failure curves (1 minus survival) suggests that the protective effect of early physiotherapy remained for a long time, whereas the proportion of patients with a diagnosis of secondary lymphoedema in the control group increased progressively (fig 4).

Fig 4 Failure time for development of secondary lymphoedema by group

Fig 4 Failure time for development of secondary lymphoedema by group

Discussion

Early physiotherapy with an educational strategy after surgery for breast cancer that involved dissection of axillary lymph nodes was associated with a lower risk of secondary lymphoedema than the educational strategy only (control group) after 12 months of follow-up: 25% in the control group compared with 7% in the intervention group. Secondary lymphoedema developed from six to 12 months postoperatively, which agrees with previous studies.29 30 This could be due to the sum of various risk factors associated with secondary lymphoedema: axillary lymph node dissection, the number of lymph nodes removed (between 10 and 20 nodes were removed in 17 of the 18 women with secondary lymphoedema), overweight (12 of the 18 women had a body mass index >25), and postoperative complications (all 18 women had postoperative complications) along with the effect of radiotherapy (completed in the fourth postoperative month) as well as the gradual weight gain (11 of 12 women with secondary lymphoedema who were overweight at baseline progressively increased in weight from six months after surgery).18 20 21 23 24 Further investigation of these risk factors is needed. Secondary lymphoedema is thought to be caused by damage to the axillary lymphatic system, impairing lymph drainage from the arm, although there is strong evidence that total blood flow in the arm and vascular bed size are increased in secondary lymphoedema.1 Recently, a study to develop an animal model of postsurgical lymphoedema reported that after nodal excisions the limbs became progressively more oedematous up to three days after node dissection and that the swelling decreased but had not resolved 16 weeks after surgery.58 Taking this into account and since the basic rule is that all oedemas result from an imbalance between filtration and resorption (tissue drainage), the implementation of a measure to restore this balance during the period of higher filtration should prevent or delay the onset of secondary lymphoedema. Our study included manual lymph drainage, which is a special method involving gentle massage to improve the lymph circulation, especially subcutaneous circulation, to stimulate the initial lymphatics, and to stretch the lymph vessels, consequently improving the removal of interstitial fluid. Manual lymph drainage encourages and improves resorption without increasing filtration.34 59 It has been shown to be effective in the treatment of lymphoedema because it improves the removal of fluid from interstitial space.32 34 59 60 We therefore think that the implementation of manual lymph drainage after surgery for breast cancer in the early physiotherapy group could have contributed to the better results in that group. This, together with early physiotherapy for other effects of breast cancer surgery, and related to the onset of secondary lymphoedema,18 20 21 23 24 could explain the effectiveness of early physiotherapy in the prevention of secondary lymphoedema in women who have had surgery for breast cancer with axillary lymph node dissection—at least during the first year after surgery. We also found that 12 of the 18 women who developed secondary lymphoedema had axillary web syndrome during the second and third week after surgery. The axillary web syndrome is a known but poorly studied complication of surgery.54 61 62 No study has shown any link between the axillary web syndrome and the onset of secondary lymphoedema. We and others32 50 suggest that the axillary web syndrome may be a sign of injury to the lymphatic system and it could produce a lymphatic overload as a result of failure of the lymphatic system. This overload, together with other factors, could be responsible for the onset of secondary lymphoedema. When axillary web syndrome was diagnosed in the postoperative period in the intervention group, specific manual lymph drainage strokes were applied, together with progressive active and action assisted shoulder and arm exercises. Manual lymph drainage acted on the pain and inflexibility inherent to the vascular inflammation of the lymphatic vessel; also, if the axillary web syndrome did produce a lymphatic overload, and therefore a possible subclinical oedema, the action of the manual lymph drainage could help with reabsorption.32 34 59 60 63 Further research on a possible relation between the axillary web syndrome and the development of secondary lymphoedema in women after breast cancer surgery is needed.

Comparison with other studies

Secondary lymphoedema is a common complication of breast cancer surgery.2 3 4 5 As far as we are aware, only one study has examined the effect of exercise and specific recommendations about self care to minimise the onset of secondary lymphoedema.29 30 In addition, several studies on the effectiveness of early rehabilitation after breast surgery reported data on lymphoedema as secondary end points.64 65 66 67 68 Box and colleagues evaluated an intervention to minimise postoperative lymphoedema in 65 women and stated that a physiotherapy management care plan, including exercise strategies that were not described in the paper, and progressive educational strategies may reduce the occurrence of secondary lymphoedema two years after surgery.30 Our results for onset of secondary lymphoedema one year after surgery are better than their results. Exercise is used in the management of secondary lymphoedema of the arm to promote the recruitment of collateral lymphatics pathways.69 This might explain the difference in results between the studies. The intervention programme in the study by Box and colleagues did not include the diagnosis and treatment of postoperative vascular complications (such as seroma and axillary web syndrome), which could be related to the onset of lymphoedema and could benefit from a proper manual physiotherapy.50 51 52 53 Many studies have assessed the effectiveness of rehabilitation in patients after breast cancer surgery.64 65 66 67 68 All of them present limitations in the sample size and assert that physiotherapy is beneficial for shoulder mobility and functional capacity without causing adverse effects in the postoperative period, but not in preventing secondary lymphoedema. All the studies focused on the recovery or maintenance of the mobility of the shoulder so that the intervention was based on mobility and stretching exercises of the shoulder.64 65 66 67 68 Only one study included massage (not manual lymph drainage) in one of the intervention groups. This group showed better results, but the onset of lymphoedema was not prevented.65 The development of restricted shoulder mobility is one of the most important factors impairing functional activities of patients after breast surgery.70 A delayed onset physiotherapy programme as required has been suggested to improve shoulder mobility and daily activities of living.71 None of these studies could correlate the exercise programme with the incidence of lymphoedema.64 65 66 67 68 Our results in relation to the study by Box and colleagues30 could result from the early diagnosis and treatment of postoperative vascular complications.

Strengths and limitations of the study

We believe that our study shows evidence of the positive effect of early physiotherapy in the prevention of secondary lymphoedema, but the study is limited by the duration of follow-up (one year after surgery) and recruitment in just one hospital. Although we have no reason to suspect systematic differences in care provided by this hospital and other regional hospitals or hospitals in other developed countries, this may limit the external validity of the results. Furthermore, that the physiotherapy was provided by trained physiotherapists may limit the generalisability of this intervention to other settings. Another limitation is that we chose a particular criterion for diagnosing lymphoedema. We followed the criterion specified in our protocol but other criteria could have been used. For example, if the criterion of a greater than 10% increase in the volume ratio between arms (affected v unaffected) had been chosen, the patients with a diagnosis of secondary lymphoedema would be those appearing to the right of the vertical line furthest to the right in figure 2. Using this criterion the early physiotherapy group would have three cases (5%) and the control group 13 (23%), with a risk ratio of 0.22 (95% confidence interval 0.06 to 0.74); results similar to those in table 2. A further limitation is the possibility of measurement errors. We have no reason to believe, however, that this will have a differential effect on both intervention and control groups. The physiotherapist who took the measurements was blinded to the patient’s treatment allocation. Both groups were reasonably balanced for baseline characteristics. The use of ratios between arms also reduces errors that could be correlated with some patient characteristics, such as body mass index. In general, we believe that measurement error might have the effect of slightly increasing the variance in the measurement, but not in a biased way. At the most, this would reduce statistical power of the comparisons to identify differences but would not invalidate the ones observed.

Conclusion

Early physiotherapy could help to prevent and reduce secondary lymphoedema in patients after breast cancer surgery involving dissection of axillary lymph nodes, at least for one year after surgery. This result emphasises the role of physiotherapy in the awareness, prevention, early diagnosis, and treatment of secondary lymphoedema. Secondary lymphoedema is a chronic condition, which has negative effects on the quality of life of patients. The increase in risk factors associated with secondary lymphoedema, such as ageing populations and the growing prevalence of obesity,18 23 24 along with the gradual improvement in rates of survival from cancer,26 suggest that secondary lymphoedema will remain a challenge. Further studies are needed to clarify whether early physiotherapy after breast cancer surgery can remain effective in preventing secondary lymphoedema in the longer term. Secondary lymphoedema is the most important chronic complication after breast cancer surgery with dissection of axillary lymph nodes Early postsurgical rehabilitation improves shoulder mobility and functional capacity without causing adverse effects but does not prevent secondary lymphoedema Early physiotherapy with an educational strategy compared with the educational strategy alone was associated with a lower risk of secondary lymphoedema 12 months after surgery for breast cancer with axillary node dissection The axillary web syndrome was an important complication in the immediate postoperative period
  45 in total

1.  Objective and subjective upper body function six months following diagnosis of breast cancer.

Authors:  Sandi Hayes; Diana Battistutta; Beth Newman
Journal:  Breast Cancer Res Treat       Date:  2005-11       Impact factor: 4.872

2.  Physical and psychological morbidity after axillary lymph node dissection for breast cancer.

Authors:  T F Hack; L Cohen; J Katz; L S Robson; P Goss
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

Review 3.  Incidence of breast carcinoma-related lymphedema.

Authors:  J A Petrek; M C Heelan
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

Review 4.  Impact of dose and volume on lymphedema.

Authors:  Luigia Nardone; Giovanni Palazzoni; Elisa D'Angelo; Francesco Deodato; M Antonietta Gambacorta; Francesco Miccichè; Alessio G Morganti
Journal:  Rays       Date:  2005 Apr-Jun

5.  [Efficacy of massage and mobilization of the upper limb after surgical treatment of breast cancer].

Authors:  B Le Vu; A Dumortier; M V Guillaume; H Mouriesse; L Barreau-Pouhaer
Journal:  Bull Cancer       Date:  1997-10       Impact factor: 1.276

Review 6.  Delayed versus immediate exercises following surgery for breast cancer: a systematic review.

Authors:  Delva R Shamley; Karen Barker; Vanessa Simonite; Anna Beardshaw
Journal:  Breast Cancer Res Treat       Date:  2005-04       Impact factor: 4.872

Review 7.  Obesity and cancer: the risks, science, and potential management strategies.

Authors:  Anne McTiernan
Journal:  Oncology (Williston Park)       Date:  2005-06       Impact factor: 2.990

8.  Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study.

Authors:  B Clark; J Sitzia; W Harlow
Journal:  QJM       Date:  2005-04-08

9.  Statistical estimation of the number of breast cancer patients with disabilities resulting from surgery.

Authors:  Yuko Kitamura; Yuko Ohno; Satoko Kasahara; Kanako Murata; Hiromi Sugiyama; Akira Oshima; Hideaki Tsukuma; Wakiko Ajiki; Toshihiko Hasegawa
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

10.  Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up.

Authors:  Sandi Hayes; Bruce Cornish; Beth Newman
Journal:  Breast Cancer Res Treat       Date:  2005-02       Impact factor: 4.872

View more
  84 in total

1.  A randomized trial of exercise on well-being and function following breast cancer surgery: the RESTORE trial.

Authors:  Roger T Anderson; Gretchen G Kimmick; Thomas P McCoy; Judith Hopkins; Edward Levine; Gary Miller; Paul Ribisl; Shannon L Mihalko
Journal:  J Cancer Surviv       Date:  2011-12-10       Impact factor: 4.442

Review 2.  Exercise in patients with lymphedema: a systematic review of the contemporary literature.

Authors:  Marilyn L Kwan; Joy C Cohn; Jane M Armer; Bob R Stewart; Janice N Cormier
Journal:  J Cancer Surviv       Date:  2011-10-16       Impact factor: 4.442

3.  The efficacy of exercise therapy in reducing shoulder pain related to breast cancer: a systematic review.

Authors:  Barbara Tatham; Jenna Smith; Oren Cheifetz; Jessica Gillespie; Katie Snowden; Jessica Temesy; Lisa Vandenberk
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

4.  Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0T MRI to external measures.

Authors:  Gregory C Gardner; Joshua P Nickerson; Richard Watts; Lee Nelson; Kim L Dittus; Patricia J O'Brien
Journal:  Lymphat Res Biol       Date:  2014-03-21       Impact factor: 2.589

5.  Effects of early exercise on the development of lymphedema in patients with breast cancer treated with axillary lymph node dissection.

Authors:  Kristen M Cavanaugh
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

Review 6.  Manual lymphatic drainage for lymphedema following breast cancer treatment.

Authors:  Jeanette Ezzo; Eric Manheimer; Margaret L McNeely; Doris M Howell; Robert Weiss; Karin I Johansson; Ting Bao; Linda Bily; Catherine M Tuppo; Anne F Williams; Didem Karadibak
Journal:  Cochrane Database Syst Rev       Date:  2015-05-21

7.  The effect of prospective monitoring and early physiotherapy intervention on arm morbidity following surgery for breast cancer: a pilot study.

Authors:  Chiara Singh; Mary De Vera; Kristin L Campbell
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

Review 8.  Running away from side effects: physical exercise as a complementary intervention for breast cancer patients.

Authors:  S Casla; P Hojman; I Márquez-Rodas; S López-Tarruella; Y Jerez; R Barakat; M Martín
Journal:  Clin Transl Oncol       Date:  2014-06-04       Impact factor: 3.405

9.  A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively.

Authors:  Sheila H Ridner; Mary S Dietrich; Kandace Spotanski; Jennifer K Doersam; Michael S Cowher; Bret Taback; Sarah McLaughlin; Nicolas Ajkay; John Boyages; Louise Koelmeyer; Sarah DeSnyder; Chirag Shah; Frank Vicini
Journal:  Lymphat Res Biol       Date:  2018-08-21       Impact factor: 2.589

10.  Agreement between telerehabilitation involving caregivers and face-to-face clinical assessment of lymphedema in breast cancer survivors.

Authors:  N Galiano-Castillo; A Ariza-García; I Cantarero-Villanueva; C Fernández-Lao; C Sánchez-Salado; M Arroyo-Morales
Journal:  Support Care Cancer       Date:  2013-09-17       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.